Effect of pimobendan on TAPSE in dogs with cardiac valvular disease
Abstract
Many caridac and pulmonary disease affect right heart functions. Therefore, clinical examination of it’s systolic function has recently became important in humans, whereas it has been largely overlooked in dogs. So that in this research, the effects of pimobendan on right ventricular fractional area change (RVFAC), tricuspid annular plane systolic excursion (TAPSE), and systolic functions were analyzed in detail by echocardiography. For this purpose, 40 cases of mitral and/or tricuspid valve disease (group II) and 10 healthy dogs (group I) were included in the study. Echocardiographic examinations were repeated after giving of pimobendan (0.2 mg/kg x2 for 1 week) (group III). In the echocardiographic examinations, the values EF, EPSS, RV area (D), RV area (S), IVSd, IVSs, LVPWs, MV E, and MV A showed statistically significant differences between the groups. Also, we found that TAPSE was lower in group II (1.29) than in group I (2.25) (P<0.001), and after treatment with pimobendan, TAPSE was increased (1.41). RVFAC also decreased in the patient group, and this value increased after treatment with pimobendan, as did TAPSE, but these changes weren't statistically significant. Therefore, we concluded that right ventricular functions should be carefully monitored in patients with various heart diseases for better diagnosis, treatment, and prognosis.
Article Details
- How to Cite
-
Gonul, R., & Seddigh Nia, A. (2024). Effect of pimobendan on TAPSE in dogs with cardiac valvular disease. Journal of the Hellenic Veterinary Medical Society, 75(1), 6937–6944. https://doi.org/10.12681/jhvms.33507
- Issue
- Vol. 75 No. 1 (2024)
- Section
- Research Articles
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
· Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non-Commercial License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
· Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g. post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
· Authors are permitted and encouraged to post their work online (preferably in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.